In study after study, the psychoactive drug ketamine has given profound and fast relief to many people suffering from severe depression. But these studies have a critical shortcoming: Participants usually can tell whether ...
Oct 19, 2023
2
40
A saline injection treatment widely used for calcific tendinopathy—a common, painful condition caused by a build-up of calcium in the rotator cuff tendons of the shoulder—provides no meaningful benefit over placebo, concludes ...
Oct 11, 2023
0
18
A team of medical researchers from Shanghai Jiaotong University School of Medicine, Central South University and the Second Affiliated Hospital of Anhui Medical University, all in China, has found evidence suggesting that ...
A prominent childhood memory is of my grandparents living with and then dying from dementia. As is universal with dementia, there was a double blow: watching my grandparents lose their identity and seeing the suffering of ...
Sep 1, 2023
0
3
How well can we assess the strength of our own immune system? The answer is that we are surprisingly good at this. A study by Konstanz psychologist Stephanie Dimitroff examined how freshly vaccinated people assess the strength ...
Aug 16, 2023
0
1
Anxiety disorders are common among Australian children, affecting nearly 7% of those aged 4–11 years.
Jul 24, 2023
0
6
As of July 1, authorized psychiatrists have been allowed to prescribe MDMA (the chemical found in "ecstasy") to treat post-traumatic stress disorder (PTSD), and psilocybin (found in "magic mushrooms") to treat depression ...
Jul 5, 2023
0
2
Evidence from a small-scale clinical trial suggests that a variation of the advanced blood cancer immunotherapy known as CAR-T could be adapted to treat myasthenia gravis, an autoimmune disorder of the nervous system. The ...
Jun 22, 2023
0
51
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a fatal motor neuron disease that causes people to gradually lose control of their muscles. There is no cure, and current treatments focus on reducing ...
Jun 1, 2023
0
116
US pharmaceutical giant Eli Lilly on Wednesday announced its experimental Alzheimer's drug significantly slowed cognitive and functional decline, results hailed as "remarkable" by experts despite some patients experiencing ...
May 3, 2023
0
129
